Cloning and nucleotide sequence of the DNA Gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2719-2727

  Bebear, C M ^a   Grau, O ^a   Charron, A ^a   Renaudin, H ^a   Gruson, D ^a   Bebear, C ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTAMIC ACID; LEUCINE; LYSINE; QUINOLONE; SERINE; TROVAFLOXACIN; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; CLOSTRIDIUM ACETOBUTYLICUM; ESCHERICHIA COLI; MOLECULAR CLONING; MOLECULAR WEIGHT; MYCOPLASMA HOMINIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; BACTERIAL PROTEINS; BASE SEQUENCE; CLONING, MOLECULAR; DNA GYRASE; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES, TYPE II; DNA, BACTERIAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; MOLECULAR SEQUENCE DATA; MUTATION; MYCOPLASMA HOMINIS; NAPHTHYRIDINES; PLASMIDS; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T;

EID: 0033806581     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2719-2727.2000     Document Type: Article

References (49)

1. Molecular characterization of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniae
2. Determination of minimal inhibitory concentration
3. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones
4. Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis
5. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro
6. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized
7. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis
8. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates
9. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases
10. DNA gyrase, topoisomerase IV, and the 4-quinolones
11. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin
12. Molecular biology of mycoplasmas
13. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluoroquinolones
14. Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus
15. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: Novel pleiotropic effects on quinolone and coumarin activity
16. The minimal gene complement of Mycoplasma genitalium
17. Culture media for classic mycoplasmas
18. Primary targets of fluoroquinolones in Streptococcus pneumoniae
19. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
20. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus
21. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals
22. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae
23. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance
24. Bacterial diversity based on type II DNA topoisomerase genes
25. Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants, whereas ofloxacin selects topoisomerase IV mutations
26. The complete genome sequence of the gram-positive bacterium Bacillus subtilis
27. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates
28. Sequencing analysis reveals a unique gene organization in the gyrB region of Mycoplasma hominis
29. Phylogeny of mycoplasmas
30. Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins
31. Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins
32. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype
33. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish pathogen Aeromonas salmonicida
34. Cloning and characterization of the parC and pare genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: Role in fluoroquinolone resistance
35. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
36. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
37. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: Overexpression, purification, and differential inhibition by fluoroquinolones
38. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions
39. Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones
40. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC
41. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase
42. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
43. Nucleotide sequence and molecular characterization of the DNA gyrase genes from Clostridium acetobutylicum
44. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae
45. Mycoplasma and ureaplasma
46. Nucleotide sequence of the Spiroplasma citri fibril protein gene
47. Bacterial evolution
48. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli